Trichostatin A (TSA), a histone deacetylase inhibitor (HDACi), induces autophagy in osteosarcoma cells by suppressing the AKT-mTOR signaling pathway and activating FoxO1, thereby enhancing the survival of osteosarcoma cells. Here, FOXO1 is linked to osteosarcoma.